drugset / Trial / NCT00165360
Prolonged Daily Temozolomide for Low-Grade Glioma
Phase 2
Completed
46 enrolled
Dana-Farber Cancer Institute
Brigham and Women's Hospital · collabSchering-Plough · collabUniversity of Virginia · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this trial is to determine the effects (good and bad) temozolomide has on patients with low-grade glioma. It will also determine whether temozolomide is effective in preventing or delaying future tumor growth.
Timeline
- Start
- 2001-09
- Primary completion
- 2006-12
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | — | — |